(Q41200886)

28 September 2017

title

Microencapsulation and transplantation of genetically engineered cells: a new approach to somatic gene therapy (English)

1 reference

28 September 2017

0 references

1 reference

Basic D

1

1 reference

28 September 2017

Vacek I

series ordinal

2

1 reference

28 September 2017

Sun AM

series ordinal

3

1 reference

28 September 2017

publication date

1 May 1996

1 reference

Artificial Cells, Blood Substitutes, and Biotechnology

28 September 2017

published in

1 reference

28 September 2017

volume

24

1 reference

28 September 2017

issue

3

1 reference

28 September 2017

page(s)

219-255

1 reference

Improved gene expression upon transfer of the adenosine deaminase minigene outside the transcriptional unit of a retroviral vector

28 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10731199609117437

Clonal gene therapy: transplanted mouse fibroblast clones express human alpha 1-antitrypsin gene in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10731199609117437

Grafting genetically modified cells to the damaged brain: restorative effects of NGF expression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10731199609117437

Implantation of genetically engineered fibroblasts into mice: implications for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10731199609117437

Grafting fibroblasts genetically modified to produce L-dopa in a rat model of Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10731199609117437

Microencapsulated islets as bioartificial endocrine pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10731199609117437

An alternative approach to somatic cell gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10731199609117437

Transformation of mammalian cells with genes from procaryotes and eucaryotes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10731199609117437

Systemic delivery of human growth hormone by injection of genetically engineered myoblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10731199609117437

Genetically modified skin fibroblasts persist long after transplantation but gradually inactivate introduced genes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10731199609117437

Human growth hormone as a reporter gene in regulation studies employing transient gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10731199609117437

Somatic Gene Therapy for Diabetes With an Immunological Safety System for Complete Removal of Transplanted Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10731199609117437

Building a metal-responsive promoter with synthetic regulatory elements

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10731199609117437

10.3109/10731199609117437

21 January 2018

Identifiers

DOI

1 reference

28 September 2017

1 reference